Dichloroacetic Acid

Dichloroacetic Acid

SCHEMBL108299

O=C([O-])C(Cl)Cl.[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PDK1PDK2PDK3PDK4

The experimentally established mechanism targets of Dichloroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118576782-A Use and product of dichloroacetate for promoting bone defect repair 北京大学口腔医学院 2024-09-03 CN claimed
CN-110003021-B Preparation method of quaternary ammonium salt dichloroacetate with anti-leukemia activity 福建医科大学附属协和医院 2022-02-15 CN claimed
CN-108342778-B Phase-change crystal potassium bis (dichloroacetate) and preparation method thereof 萍乡学院 2020-07-17 CN claimed
US-20170253930-A1 METHODS AND COMPOSITIONS FOR INHIBITING AND TREATING NEUROLOGICAL CONDITIONS POPULATION BIO, INC. (US) 2017-09-07 US claimed
WO-2016036403-A1 METHODS AND COMPOSITIONS FOR INHIBITING AND TREATING NEUROLOGICAL CONDITIONS POPULATION DIAGNOSTICS INC. (US) 2016-03-10 WO claimed
EP-2603225-A2 ELECTRONICALLY MODIFIED REACTION INTERMIDEATES Markou, Demetrios (US) 2013-06-19 EP claimed
WO-2012024196-A2 A NOVEL METHOD FOR CREATING, SUSPENDING AND STABILIZING ELECTRONICALLY MODIFIED REACTION INTERMIDEATES MARKOU DEMETRIOS (US) 2012-02-23 WO claimed
US-20120039796-A1 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients MARKOU DEMETRIOS (US) 2012-02-16 US claimed
JP-2001514652-A 2001-09-11 JP claimed
EP-0968170-A1 METHODS FOR PREPARING PRENYL ALCOHOL LOYOLA UNIVERSITY OF CHICAGO (US) 2000-01-05 EP claimed
US-5872277-A Methods for preparing prenyl alcohol LOYOLA UNIVERSITY OF CHICAGO (US) 1999-02-16 US claimed
WO-1998040345-A1 METHODS FOR PREPARING PRENYL ALCOHOL LOYOLA UNIVERSITY OF CHICAGO (US) 1998-09-17 WO claimed
US-4942268-A HALOGENATION AN AROMATIC COMPOUND IN THE PRESENCE OF A ZEOLITE CATALYST IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1990-07-17 US claimed
US-4831199-A CHLORINATION OF SUBSTITUTED BENZENES USING CATALYST OF ZEOLITE AND ALIPHATIC CARBOXYLIC ACID IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1989-05-16 US claimed
EP-0154236-B1 PROCESS FOR PRODUCING A HALOBENZENE IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 1988-01-13 EP claimed
US-4631294-A TRAUMAS, STROKES, CARDIOVASCULAR DISORDERS UNIVERSITY E.M., INC. (US) 1986-12-23 US claimed
EP-0154236-A1 Process for producing a halobenzene IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 1985-09-11 EP claimed
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
US-4263432-A ANTIBIOTICS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1981-04-21 US disclosed
US-4198339-A INTERMEDIATES FOR PENICILLINS AND CEPHALOSPORINS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1980-04-15 US disclosed